Skip to content

Main Navigation

Locate Bio

Menu

  • Home
  • Products
    • LDGraft™
    • CertOss™
    • OsteoMime™
  • We are LocateBio
  • News
  • Contact

News

  • Clear Filters

Funding

First Participant Treated in Groundbreaking LDGraft RESTORE Study for Spinal Fusion

Funding

Locate Bio Raises £9.2m for LDGraft ALIF Study

News

Locate Bio’s LDGraft Granted FDA Breakthrough Device Designation

Resources

Locate Bio: next-generation orthobiologics

Resources

Programmed Drug Release of rhBMP-2 for Bone Healing

Funding

Locate Bio Closes £10 million Funding Round

People

Locate Bio appoints Keith Valentine as the Non-Executive Chair of the Board of Directors

Funding

Locate Bio raises £2.25m for new spinal treatments

People

Locate Bio announces the appointment of John von Benecke as CEO

Funding

Locate Bio receives £2.0 million investment from Mercia and the MEIF to expand its cell and gene therapy pipeline

News

Locate Therapeutics announces name change to Locate Bio and new investment from Mercia Technologies PLC

Loading...

Choose your region

Please select where you are visiting from

USA Outside of USA

About LocateBio

LocateBio is an innovative UK MedTech company with industry-leading drug delivery and tissue scaffold capabilities.

Links

  • Contact

Legals

  • Privacy and Cookies
  • Cookie Policy

© 2025

  • Outside USA
  • USA